Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 55% ± 17% | |
oligodendrocyte | 7 studies | 37% ± 14% | |
astrocyte | 5 studies | 26% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 50% ± 10% | |
Mueller cell | 3 studies | 22% ± 4% | |
GABAergic neuron | 3 studies | 32% ± 10% | |
glutamatergic neuron | 3 studies | 40% ± 13% | |
interneuron | 3 studies | 31% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4209.43 | 2635 / 2642 | 99% | 72.64 | 701 / 705 |
lung | 56% | 468.47 | 325 / 578 | 40% | 2.36 | 460 / 1155 |
esophagus | 1% | 6.85 | 17 / 1445 | 51% | 0.93 | 94 / 183 |
skin | 8% | 117.22 | 153 / 1809 | 30% | 1.44 | 140 / 472 |
lymph node | 0% | 0 | 0 / 0 | 34% | 0.50 | 10 / 29 |
eye | 0% | 0 | 0 / 0 | 30% | 2.32 | 24 / 80 |
spleen | 27% | 132.37 | 65 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 22% | 131.38 | 200 / 929 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 14% | 0.59 | 40 / 286 |
ovary | 0% | 0 | 0 / 180 | 12% | 0.49 | 50 / 430 |
adrenal gland | 0% | 0 | 0 / 258 | 10% | 0.31 | 22 / 230 |
uterus | 2% | 10.67 | 4 / 170 | 7% | 0.98 | 32 / 459 |
intestine | 1% | 2.86 | 7 / 966 | 8% | 0.23 | 40 / 527 |
bladder | 0% | 0 | 0 / 21 | 7% | 0.65 | 35 / 504 |
kidney | 0% | 0 | 0 / 89 | 6% | 2.44 | 53 / 901 |
adipose | 6% | 31.15 | 70 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 5% | 0.24 | 9 / 178 |
breast | 0% | 1.32 | 1 / 459 | 4% | 0.31 | 44 / 1118 |
prostate | 0% | 0 | 0 / 245 | 4% | 0.14 | 18 / 502 |
thymus | 0% | 0.52 | 1 / 653 | 3% | 0.07 | 18 / 605 |
liver | 0% | 0 | 0 / 226 | 2% | 0.51 | 7 / 406 |
blood vessel | 1% | 5.30 | 15 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.17 | 2 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.34 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031102 | Biological process | neuron projection regeneration |
GO_0007155 | Biological process | cell adhesion |
GO_0098552 | Cellular component | side of membrane |
GO_0005886 | Cellular component | plasma membrane |
Gene name | OMG |
Protein name | Oligodendrocyte-myelin glycoprotein |
Synonyms | OMGP |
Description | FUNCTION: Cell adhesion molecule contributing to the interactive process required for myelination in the central nervous system. |
Accessions | ENST00000708440.1 P23515 ENST00000247271.5 |